Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

OCUGEN ($OCGN) Releases Q1 2026 Earnings

None

OCUGEN ($OCGN) posted quarterly earnings results for Q1 2026 on Tuesday, May 5th. The company reported earnings of -$0.06 per share, missing estimates of -$0.05 by $0.01. The company also reported revenue of $1,530,000, beating estimates of $550,800 by $979,200.

You can see Quiver Quantitative's $OCGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive OCGN Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

OCUGEN Hedge Fund Activity

We have seen 63 institutional investors add shares of OCUGEN stock to their portfolio, and 35 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • GMT CAPITAL CORP removed 4,153,798 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,607,627
  • UBS GROUP AG added 3,824,474 shares (+373.2%) to their portfolio in Q4 2025, for an estimated $5,163,039
  • STATE STREET CORP added 2,623,361 shares (+193.6%) to their portfolio in Q4 2025, for an estimated $3,541,537
  • MARSHALL WACE, LLP added 2,530,956 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,416,790
  • RENAISSANCE TECHNOLOGIES LLC added 1,410,200 shares (+485.9%) to their portfolio in Q4 2025, for an estimated $1,903,770
  • VANGUARD GROUP INC added 1,251,977 shares (+8.2%) to their portfolio in Q4 2025, for an estimated $1,690,168
  • MILLENNIUM MANAGEMENT LLC added 1,234,268 shares (+29.7%) to their portfolio in Q4 2025, for an estimated $1,666,261

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

OCUGEN Analyst Ratings

Wall Street analysts have issued reports on $OCGN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Chardan Capital issued a "Buy" rating on 01/20/2026

To track analyst ratings and price targets for OCUGEN, check out Quiver Quantitative's $OCGN forecast page.

OCUGEN Price Targets

Multiple analysts have issued price targets for $OCGN recently. We have seen 4 analysts offer price targets for $OCGN in the last 6 months, with a median target of $10.0.

Here are some recent targets:

  • Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $10.0 on 03/25/2026
  • Daniil Gataulin from Chardan Capital set a target price of $7.0 on 03/25/2026
  • Whitney Ijem from Canaccord Genuity set a target price of $12.0 on 03/17/2026
  • Leland Gershell from Oppenheimer set a target price of $10.0 on 03/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles